Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Clinical Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • Clinical Compendia
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • Quality Improvement Sucess Stories
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
    • Clinical Compendia
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
  • Advertising
  • Reprints/Reuse
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • Instructions for Authors
    • ADA Journal Policies
Departments

The Future of Diabetes: What Is There Besides New Medicines?

  1. Frank Vinicor, MD, MPH
    Clinical Diabetes 2004 Apr; 22(2): 94-96. https://doi.org/10.2337/diaclin.22.2.94
    PreviousNext
    • Article
    • Info & Metrics
    • PDF
    Loading

    Sometimes—if one gets a chance—it can be refreshing to step back from the daily demands of medical management of diabetes and think about what opportunities lie ahead, in addition to new medicines, that could help reduce the diabetes burden. Certainly, over the past few decades, we 1) have learned much about diabetes; 2) are generally doing better for people with diabetes (although we still have a ways to go); and 3) have become aware that more and more people with diabetes are going to need health care. What is out there to think about? While important and exciting research continues, listed below and briefly discussed are 10 other challenges for the diabetes community over the next few decades.

    1. Continuing the Improvements in Diabetes Care

    Most recent studies have documented that diabetes care is gradually getting better.1 Whether measured by preventive behaviors of patients and/or health professionals, laboratory results, or other outcomes, there has been steady improvement in both diabetes management and the consequences of that management.

    Certainly, not all people with diabetes are experiencing these benefits. We always have to be careful about “publication bias” (i.e., only positive results are published), and the glass is not completely filled (although it does seem to be filling up). The last 30% or so of the “diabetes care glass” may be more difficult than the first 70%, because we may have influenced the so-called early adopters (i.e., tackled those challenges that require some, but not complex management strategies and worked mainly with those people with diabetes who have the resources, jobs, education, and so forth to more easily benefit from our efforts).2 But we have gained ground and need to continue these efforts, both to achieve improved outcomes and to document that improvement.

    2. Recognizing and Addressing the Complexities of Diabetes Management

    Although controlling glucose metabolism has been a persistent goal over the years, it seems like the “metabolic challenge” has become more complex. With advancement in diabetes science, we now know that cardiovascular risk management also makes a large difference in the lives of people with diabetes.3,4 Awareness of the interactions of diabetes and mental health adds to the complexity.5 We have more, but better, medications; more, but improved, glucose testing equipment; greater complexity (and confusion?) about nutrition; less simplicity about diabetes classification (what is type 2 diabetes among youth or latent autoimmune diabetes of adults [LADA]?).6 All of these issues add further to the usual complexity of diabetes.

    And at an even more fundamental level, people with diabetes are first and foremost “human” (i.e., they are not protected from usual nondiabetic conditions such as cancer or flu). They must receive appropriate preventive measures for these challenges on top of the usual demands of diabetes.7

    3. Improving the “System of Care”

    As so clearly articulated by the Institute of Medicine’s report, “Crossing the Quality Chasm: a New Health Care System for the 21st Century,”8 there is no real system of care in the United States, and what systems of care exist, were primarily designed for infectious/acute diseases. Where deficiencies in quality of care exist (and they do), it is usually a problem with the design and workings of the health system—rather than failures of individual health professionals—that eventuates in both poor quality of care and “medical errors.”

    As individual health professionals, we nevertheless have responsibilities to make things better. Increasingly, this means redesigning health systems for chronic disease management.9 This is possible, and indeed a necessity, if we are to fill the “diabetes care glass” fully.10

    4. Broadening the Definition of the “Office”

    Given that people with diabetes spend so much more time outside the office/clinic—at home, work, or play—than in direct contact with health professionals, we need to find ways to extend educational and management efforts initially provided in the office into the real world. Community health workers, Internet information, telecommunications, automated phone calls—these are some of the present efforts to expand the traditional office, to bring medical information to the patient, to design a sort of 21st-century house call.8,11,12

    5. Addressing the Dual Impact of the Diabetes Epidemic

    Given the epidemic of type 2 diabetes in the United States (and the world),13 two challenges must be recognized : 1) maintaining efforts to improve the management of those with diabetes when there will likely be more patients with type 2 diabetes and hence less time per patient to manage an increasingly complex condition called “diabetes”; and 2) developing and implementing primary prevention programs, usually outside the office, for those at high risk for developing type 2 diabetes. All of this in a situation of limited resources, time, and experience. How can we both reduce incidence and improve quality of care? Yet, we must!

    6. Recognizing and Dealing With “Non-Health Forces” on Diabetes Prevention and Control

    Health care is not immune to the impact of powerful factors outside the medical office that affect our abilities to prevent and manage diabetes well. Large governmental deficits at both the state and federal levels, a poor economic situation, governmental attention to other important areas such as foreign policy—all will affect commitments to diabetes research, availability of improved pharmacological interventions/programs, and extent of health insurance.2,14 Within a world of limits, health can deteriorate because of the power and dominance of these types of factors that are typically viewed as “outside the medical office.”15

    7. Taking Special Opportunities for Health Professionals

    Health professionals are given remarkable power and trust by society.16 And that power and trust extends beyond the office and the provision of medical care per se. It allows us to influence well beyond our sheer numbers issues that ultimately affect health. We certainly need to maintain that trust and power provided by the people,17 but also become involved in important health issues that occur outside our offices, such as school nutrition and activity programs and issues of the uninsured.15

    8. Empowering Patients for More Than Good Self-Care

    Increasingly for chronic disease prevention and management, individuals with or at risk for the condition are viewed as central to improved health.18 Although empowerment is now an important approach to diabetes self-management,19 our expectations of our patients should be more; we should help them speak out about important issues that could affect the health of others. It has worked for the HIV community, and it should work for diabetes. The voice of the people can influence policymakers, politicians, and other decision makers, perhaps more than we can ourselves.20 People with diabetes and their families have a right and an opportunity to speak out, not only for their own health, but for that of their community.

    9. Achieving a Balance Between Individuality and Community

    Our country was provided “operational guidance” by the U.S. Constitution, and although this document certainly articulates the benefits of individuality, it also addresses the vital importance of community.21 On balance, we have benefited by facilitating individual creativity. In health, however, and within a world of limits, a “communitarian” viewpoint also has merit. Perhaps some will have to give up what they want so that all or at least more can have what they need.22 Making decisions as a community is ethical and reasonable and likely to be very helpful for all people with or at risk for diabetes.

    10. Accepting and Embracing Globalization

    We generally think of globalization in terms of economics. But more than metaphorically, if China sneezes, the U.S. catches a cold.23 Not only is the epidemic of type 2, and perhaps type 1, diabetes occurring worldwide,13,24 but also the exporting of our “goods”—be they cigarettes, food, or physically inactive lifestyles—can further spread the diabetes epidemic. In addition, we can learn from other countries regarding approaches to diabetes prevention and control. We are part of an ever-shrinking world, and we need to think about more than our own office, city, state, or country.25,26

    Conclusion

    In summary, although I am sure there are other important forces, opportunities, and challenges associated with diabetes in the near and distant future, and although I know there are only 24 hours in the day, I firmly believe that consideration of the above 10 issues as future challenges and opportunities will allow some progress to be made. People with or at risk for diabetes will be better off. We will have made a difference.

    Footnotes

    • Frank Vinicor, MD, MPH, is director of the Division of Diabetes Translation at the Centers for Disease Control and Prevention in Atlanta, Ga.

    • American Diabetes Association

    References

    1. ↵
      Vinicor F: Quality of care and diabetes mellitus. Curr Opin Endocrinol Diabetes 8:58–66, 2001
      OpenUrl
    2. ↵
      Schroeder S: Prospects for expanding health insurance coverage. New Engl J Med 344:847–852, 2001
      OpenUrlCrossRefPubMedWeb of Science
    3. ↵
      Lteif A, Mather K, Clark C: Diabetes and heart disease: an evidence-driven guide to risk factors management in diabetes. Cardiol Rev 11:262–274, 2003
      OpenUrlCrossRefPubMed
    4. ↵
      Gavin J, Peterson K, Warren-Boulton E: Reducing cardiovascular disease risk in patients with type 2 diabetes: a message from the National Diabetes Education Program. Am Fam Physician 68:1569–1574, 2003
      OpenUrlPubMed
    5. ↵
      Finkelstein E, Bray J, Chen H Larson MJ, Miller K, Tompkins C, Keme A, Manderscheid R: Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care 26:415–420, 2003
      OpenUrlAbstract/FREE Full Text
    6. ↵
      Unwin N, Shaw J, Zimmet P, Alberti KG: Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetic Med 19:708–723, 2002
      OpenUrlCrossRefPubMedWeb of Science
    7. ↵
      Strickler HD, Wylie-Rosett J, Rohan T, Hoover DR, Smoller S, Burk RD, Yu H: The relation of type 2 diabetes and cancer. Diabetes Technol Ther 3:263–274, 2001
      OpenUrlCrossRefPubMed
    8. ↵
      Institute of Medicine: Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, D.C., National Academy Press, 2001
    9. ↵
      Bodenheimer T, Wagner E, Grumback K: Improving primary care for patients with chronic illness. JAMA 288:1775–1779, 2002
      OpenUrlCrossRefPubMedWeb of Science
    10. ↵
      Berwick D: Disseminating innovations in health care. JAMA 289:1969–1975, 2003
      OpenUrlCrossRefPubMedWeb of Science
    11. ↵
      Klonoff D: Diabetes and telemedicine: is the technology sound, effective, cost-effective and practical? Diabetes Care 26:1475–1479, 2003
      OpenUrlAbstract/FREE Full Text
    12. ↵
      American Association of Diabetes Educators: Diabetes community health workers. Diabetes Educ 29:821–824, 2003
      OpenUrl
    13. ↵
      King H, Aubert R, Herman W: Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414–1431, 1998
      OpenUrlAbstract/FREE Full Text
    14. ↵
      Larme A, Pugh J: Evidence-based guidelines meet the real world: the case of diabetes care. Diabetes Care 24:1728–1733, 2001
      OpenUrlAbstract/FREE Full Text
    15. ↵
      McGinnis JM: A vision for health in our new century. Am J Health Promotion 18:146–150, 2003
      OpenUrlPubMedWeb of Science
    16. ↵
      Terry P: Leadership and achieving a vision: how does a profession lead a nation? Am J Health Promotion 18:162–167, 2003
      OpenUrlPubMed
    17. ↵
      Berwick D, Davidoff R, Hiatt H, Smith R: Refining and implementing the Tavistock principles for everybody in health care. BMJ 323:616–620, 2001
      OpenUrlFREE Full Text
    18. ↵
      Bodenheimer T, Lorig K, Holman H, Grumbach K: Patient self-management of chronic disease in primary care. JAMA 288:2469–2475, 2002
      OpenUrlCrossRefPubMedWeb of Science
    19. ↵
      Funnell M, Anderson R: Patient empowerment: a look back, a look ahead. Diabetes Educ 29:454–458, 2003
      OpenUrlFREE Full Text
    20. ↵
      Beauchamp D: Health Care Reform and the Battle for the Body Politic. Philadelphia, Pa., Temple University Press, 1996
    21. ↵
      Padover S: The Living U.S. Constitution. 3rd ed. New York, Penguin Books, 1995
    22. ↵
      Callahan D: False Hopes: Why America’s Quest for Perfect Health is a Recipe for Failure. New York, Simon and Schuster, 1998
    23. ↵
      Hughes J: The SARS response: building and assessing the evidence-based approach to future global microbial threats. JAMA 290:3251–3252, 2003
      OpenUrlCrossRefPubMed
    24. ↵
      Soltesz G: Diabetes in the young: a paediatric and epidemiological perspective. Diabetologia 46:447–454, 2003
      OpenUrlCrossRefPubMedWeb of Science
    25. ↵
      Zimmet P: Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday Scenario be averted? J Intern Med 247:301–310, 2000
      OpenUrlCrossRefPubMedWeb of Science
    26. ↵
      Frenk J, Gomez-Dantes O: Globalization and the challenges to health systems. Health Affairs 21:160–165, 2002
      OpenUrlFREE Full Text
    PreviousNext
    Back to top

    In this Issue

    April 2004, 22(2)
    • Table of Contents
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Clinical Diabetes.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    The Future of Diabetes: What Is There Besides New Medicines?
    (Your Name) has forwarded a page to you from Clinical Diabetes
    (Your Name) thought you would like to see this page from the Clinical Diabetes web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    The Future of Diabetes: What Is There Besides New Medicines?
    Frank Vinicor
    Clinical Diabetes Apr 2004, 22 (2) 94-96; DOI: 10.2337/diaclin.22.2.94

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    The Future of Diabetes: What Is There Besides New Medicines?
    Frank Vinicor
    Clinical Diabetes Apr 2004, 22 (2) 94-96; DOI: 10.2337/diaclin.22.2.94
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • 1. Continuing the Improvements in Diabetes Care
      • 2. Recognizing and Addressing the Complexities of Diabetes Management
      • 3. Improving the “System of Care”
      • 4. Broadening the Definition of the “Office”
      • 5. Addressing the Dual Impact of the Diabetes Epidemic
      • 6. Recognizing and Dealing With “Non-Health Forces” on Diabetes Prevention and Control
      • 7. Taking Special Opportunities for Health Professionals
      • 8. Empowering Patients for More Than Good Self-Care
      • 9. Achieving a Balance Between Individuality and Community
      • 10. Accepting and Embracing Globalization
      • Conclusion
      • Footnotes
      • References
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Transitioning to Fixed-Ratio Combination Therapy: Five Frequently Asked Questions Health Care Providers Should Anticipate From Their Patients
    • Gvoke HypoPen: An Auto-Injector Containing an Innovative, Liquid-Stable Glucagon Formulation for Use in Severe Acute Hypoglycemia
    • Timely News and Notes for Primary Care Providers from the American Diabetes Association
    Show more Departments

    Similar Articles

    Navigate

    • Current Issue
    • Papers in Press
    • Abridged Standards of Care
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes
    • Diabetes Care
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Clinical Diabetes Print ISSN: 0891-8929, Online ISSN: 1945-4953.